CSS
TECH icon

Cubist Systematic Strategies’s Bio-Techne TECH Stock Holding History

Cubist Systematic Strategies’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,100
Closed -$641K – 3987
2024
Q1 		$641K Hold
9,100
– – ﹤0.01% 2471
2023
Q4 		$702K Buy
+9,100
New +$599K ﹤0.01% 2318

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Cubist Systematic Strategies's TECH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 88,206 shares — an estimated $4.54M sold.

Cubist Systematic Strategies first reported a position in TECH in Q3 2014 and held it in 26 quarters. The position peaked at $10.9M in Q3 2022. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 88,206 Bio-Techne shares in Q3 2025, an estimated $4.54M.
  • Cubist Systematic Strategies first reported a position in Bio-Techne in Q3 2014 and held it in 26 quarters.
  • Cubist Systematic Strategies's Bio-Techne position peaked at $10.9M in Q3 2022.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.